infectious diseases pta 120 pathophysiology day 16
TRANSCRIPT
![Page 1: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/1.jpg)
INFECTIOUS DISEASES
PTA 120 Pathophysiology
Day 16
![Page 2: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/2.jpg)
Objectives
Describe the reasons why infections can occur both at the cellular level and the organism level.
Define infectious diseases including signs and symptoms of each: Hepatitis HIV / AIDS Cytomegalovirus Syphilis Nosocomial Infections
![Page 3: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/3.jpg)
Objectives
West Nile Virus Diseases which require immunity in health care
workers Botulism Influenza Meningitis
Discuss how infectious pathologies can adversely affect function requiring the modification of treatment intervention to protect the patient from worsening the condition and optimize treatment outcomes.
![Page 4: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/4.jpg)
Objectives
Discuss the modifications and precautions that may be required for the treatment of patients with infectious disorders.
Demonstrate understanding of the PTA’s role in the disease process and infection control.
![Page 5: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/5.jpg)
Textbooks
Pathology for Physical Therapist Assistants, Ch 10
Physical Therapy Clinical Handbook for PTAs, Section 1-6
![Page 6: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/6.jpg)
QUICK REVIEW
Physiology of Infection
![Page 7: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/7.jpg)
Why Do Infections Occur?
Factors involved in infectionPortal of entryVirulence of organism
Aggressiveness Toxin production
Dose (number) of pathogensIndividual condition (predisposition) to
infection
![Page 8: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/8.jpg)
Modes of Transmission
Direct physical contact Mucous membranes Intact skin Broken skin
Indirect physical contact Inhalation Ingestion
From Christensen BL, Kockrow ED: Foundations of nursing, ed 5, 2006, St. Louis, Mosby.
![Page 9: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/9.jpg)
When infection occurs
Phagocytosis White blood cells take in and destroy waste and
foreign material Neutrophils Macrophages
Natural Killer Cells Type of lymphocyte Can recognize body cells with abnormal membranes Found in lymph nodes, spleen, bone marrow, blood Secrete protein that breaks down cell membrane
![Page 10: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/10.jpg)
THE PTA MUST MAKE INFORMED DECISIONS ABOUT VACCINATIONS AND
INFECTION CONTROL, AS HEPATITIS B IS A BLOOD-BORNE PATHOGEN MORE LIKELY
TO BE CONTRACTED BY HEALTH CARE WORKERS.
Why does the PTA need to know about Hepatitis?
![Page 11: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/11.jpg)
Hepatitis
Group of liver infections and diseases caused by various viruses
Several types Hepatitis A (HAV) Hepatitis B (HBV) Hepatitis C (HCV) Hepatitis D (HDV) Hepatitis E (HEV) Hepatitis G (GEV) Alcoholic Hepatitis
![Page 12: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/12.jpg)
Hepatitis
Hepatitis A (HAV) Transmitted through contact with body fluids, feces,
and ingestion of contaminated food and drinking water
Hepatitis D (HDV), E (HEV) and G (HGV)
Alcoholic hepatitis A chronic and serious condition of the liver caused by
extreme alcohol intake
![Page 13: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/13.jpg)
Hepatitis B
Description CDC estimates 800,000 to 1.4 million people in U.S.
have chronic hepatitis 350,000,000 affected, 620,000 deaths worldwide
annually Males between 25 and 44 most affected Risk for infection greatest in people with
immunosuppressive disorders and health care workers Vaccinations recommended for children and health
care workers Virus lives on equipment up to 7 days OSHA and CDC recommendations for clean-up
![Page 14: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/14.jpg)
Hepatitis B
Etiology DNA virus, blood – borne pathogen Transmitted through contact with contaminated
blood, blood products, or through sexual contact Incubation period from 6 weeks to 6 months
Symptoms Loss of appetite, nausea and vomiting Weakness, fatigue, joint and muscle pains, aching Fever, skin rash Jaundice, dark-colored urine
![Page 15: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/15.jpg)
Hepatitis B
Treatment Prevention, vaccinations Medications
![Page 16: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/16.jpg)
Physical Therapy Interventions
For Hepatitis B
Treatment is not directly indicated for patients with Hepatitis B
Standard PrecautionsImmunizations
![Page 17: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/17.jpg)
Hepatitis C
Description > 85% develop chronic form > 4 million in U.S. and 180 million worldwide affected
Etiology RNA virus, transmitted through blood Transmitted via infected blood Most common in those persons who use IV illicit drugs
or have multiple sexual partners
![Page 18: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/18.jpg)
Hepatitis C
Signs and Symptoms Usually mild Reduction in appetite, abdominal pain, tenderness
over liver region Muscle and joint pain Jaundice, cirrhosis
Treatment Prevention Medications for progressive forms Possible liver transplant if severe
![Page 19: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/19.jpg)
Physical Therapy Interventions
For Hepatitis C
Treatment is indicated for associated arthritis and fibromyalgia, which result in functional deficits, and is focused on improving function, increasing joint mobility, strengthening, endurance, and education on energy conservation techniques.
![Page 20: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/20.jpg)
THE PTA MAY WORK WITH PEOPLE WITH HIV OR AIDS IN VARIOUS SETTINGS, WITH
SOME PATIENTS IN THE END STAGES OF THE DISEASE. A CLEAR KNOWLEDGE OF
THE DISEASE IS NECESSARY TO UNDERSTAND APPROPRIATE PRECAUTIONS
AND MYTHS AB OUT THE DISORDER.
Why does the PTA need to know about HIV / AIDS?
![Page 21: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/21.jpg)
HIV/AIDS
Description HIV = human immunodeficiency virus
Sexually transmitted viral disease
AIDS = acquired immune deficiency syndrome Failure of body to develop antibodies to infecting organisms
Worldwide deaths = 25 million
Worldwide people living with the disease = 33.4 million
Most affected in Africa and Asia; 2/3 of all people with AIDS live in sub-Saharan Africa
Homosexual and bisexual men; African American men and women
![Page 22: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/22.jpg)
AIDS
Etiology Blood-borne pathogen; several viruses exist, including HIV 1
and 2
May remain undetectable in the blood and person may / may not show symptoms for prolonged time
Body fails to develop antibodies (vs. attacking its own cells) -> susceptible to opportunistic infections -> body does not recognize or defend itself -> infections become life threatening
RNA retrovirus, attaches to CD4 receptor of T-lymphocytes; requires reverse transcriptase to multiply
![Page 23: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/23.jpg)
AIDS
Rate of disease progression = rate that the virus attacks more T-lymphocytes
Transmitted through blood and bodily fluids Sexually Shared hypodermic needles Blood transfusions in early 1980s
![Page 24: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/24.jpg)
AIDS
Signs and Symptoms Flu-like initially
Long-term Weight loss, chronic diarrhea Chronic fatigue, generalized progressive weakness Joint arthritis AIDS dementia complex Neurological symptoms
Secondary / opportunistic infections
![Page 25: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/25.jpg)
AIDS
Treatment Pharmacology
“soup” or “cocktail” HAART – highly active antiretroviral therapy to improve
T-cell count, suppress HIV replication, reduces incidence of opportunistic infections
![Page 26: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/26.jpg)
Physical Therapy Interventions
For HIV / AIDS
Treatment is indicated for muscle weakness and atrophy, fatigue, peripheral neuropathy, coordination problems, and AIDS dementia complex. Education of the patient and care providers includes transfer and ambulation training, as well as any assistance required for daily living activities.
Patients often benefit from physical touch, as they are often isolated.
Diagnosis of HIV / AIDS must be kept confidential for privacy reasons.
![Page 27: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/27.jpg)
T H E S E D I S E A S E S A R E S E E N F R E Q U E N T LY I N T H E G E N E R A L P O P U L AT I O N, A N D M AY B E S E E N I N P H Y S I C A L T H E R A P Y F O R A S S O C I AT E D J O I N T,
M U S C L E , A N D M O B I L I T Y P R O B L E M S . I T I S I M P O R TA N T T O U N D E R S TA N D T H E T R A N S M I S S I O N O F T H E S E D I S E A S E S T H R O U G H B L O O D A N D B O D Y F LU I D
C O N TA C T, A N D T H E I M P O R TA N C E O F S TA N D A R D P R E C A U T I O N S T O P R E V E N T T H E S P R E A D O F D I S E A S E .
Why does the PTA need to know about sexually transmitted
diseases?
![Page 28: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/28.jpg)
Cytomegalovirus
Description CMV Most common congenital virus in U.S.; 1 in 150
infants affected, 1 in 5 develop permanent disability Related to herpes viruses
Etiology Present in all body fluids, transmission through close
contact with infected fluids May be passed to fetus through pregnancy or breast
milk
![Page 29: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/29.jpg)
Cytomegalovirus
Signs and Symptoms May or may not be present; may mimic influenza Newborn symptoms: low birth weight, microcephaly,
respiratory problems mental and motor delays, seizures,
In immunocompromised: colitis, pulmonary infections, encephalitis, neuropathy, retinitis
Organ transplant patientsTreatment
Infants treated with antiviral medication to prevent hearing loss
Antiviral medications for complications
![Page 30: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/30.jpg)
Physical Therapy Interventions
For Cytomegalovirus
Physical therapy is not directly indicated for CMV, but it is extremely important to follow Standard Precautions, with particular attention paid to hand washing and glove wearing.
It is often highly recommended that PTs, PTAs, and all other health care workers who are or might be pregnant do not work with patients with CMV, as the virus could possibly be spread to the fetus.
![Page 31: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/31.jpg)
Syphilis
Description Sexually transmitted bacterial disease 36,000 diagnosed in U.S. in 2006 Congenital syphilis; women 20 – 24 years of age; men =
35 – 39 years of age
Etiology Bacteria Treponema pallidum Spread through sexual contact with chancre (open sore) Indirect contact with contaminated surfaces Incubation period of 3 weeks; transmitted to fetus after
10th week of pregnancy
![Page 32: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/32.jpg)
Syphilis
Signs and Symptoms Primary stage: infectious, small, painless chancres on genitalia,
anus, lips, mouth; heals without treatment
Secondary stage: infectious, red-brown rash on soles of feet and palms; fever, sore throat, headaches and muscle aches, weight and hair loss, fatigue
Tertiary or late-stage: affects internal organs Tabes dorsalis (progressive locomotor ataxia), syphilitic spinal
sclerosis – infection of spinal cord Sensory nerve axons destroyed Dementia, incoordination (ataxic gait); paralysis, weakness,
numbness, blindness, deafness, severe pain, death Syphilitic arthritis
![Page 33: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/33.jpg)
Syphilis
Treatment Penicillin by intramuscular injection Regular screening Education on avoiding at risk behaviors and condom
use to avoid spreading the disease
![Page 34: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/34.jpg)
Physical Therapy Interventions
For Syphilis
Physical therapy is not directly indicated for the primary and secondary stages, but may be needed in the late stage for neurological or musculoskeletal manifestations of the disease.
![Page 35: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/35.jpg)
NOSOCOMIAL INFECTIONS ARE COMMONLY FOUND IN HOSPITALS AS WELL AS EXTENDED
CARE FACILITIES. KNOWLEDGE OF THESE INFECTIONS IS CRITICAL TO UNDERSTANDING THE PRECAUTIONS NECESSARY IN ORDER TO PREVENT THE SPREAD OF THE INFECTION TO
OTHER PATIENTS OR TO HIMSELF.
Why does the PTA need to know about nosocomial infections?
![Page 36: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/36.jpg)
Nosocomial Infections
Description Hospital – acquired, health care-associated
5 infections / 1,000 patient days in the hospital
Result in 26,250 deaths per year; focus on decreasing length of hospital stays
![Page 37: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/37.jpg)
Nosocomial Infections
Etiology Caused by viruses, bacteria, and fungi
Most common agents are Streptococci, Staphylococcus aureus, Enterococci, Pseudomonas, Escherichia coli, and Enterobacter species
Intensive care units
Risk increases with invasive procedures ( IV lines, catheters, intubation)
![Page 38: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/38.jpg)
Nosocomial Infections
Etiology Risk factors in 3 groups:
Patient-related: seriousness of illness, whether the immune system is compromised, and length of stay needed
Organizational: contamination of air-conditioning or water systems, how close together patient beds are placed, and nurse-to-patient ratio
Iatrogenic: associated with pathogens on hands of health care team
![Page 39: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/39.jpg)
Nosocomial Infections
Signs and Symptoms Develop a fever while in hospital Related to invasive procedure performed Fever, skin rash, fatigue, tachycardia
Treatment Broad spectrum antibiotic until exact cause is known Antibacterial, antiviral, antifungal medications Removal of catheters or lines thought to be the source Prevention; handwashing
![Page 40: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/40.jpg)
Physical Therapy Interventions
For Nosocomial Infections
Physical therapist assistants are responsible for preventing the spread of infections through following standard precautions and meticulous hand-washing after patient contact and / or handling any lines.
![Page 41: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/41.jpg)
A PTA MAY ENCOUNTER THESE DISEASES B OTH IN THE U.S. AND WHEN TRAVELING AROUND THE WORLD. IS IMPORTANT TO
KNOW HOW TO PREVENT THE DISEASES IN THEMSELVES, AS WELL AS RECOGNIZING
S IGNS AND SYMPTOMS IN PATIENTS THEY TREAT THAT MAY HAVE THESE INFECTIONS.
Why does the PTA need to know about vector- and animal-borne
infectious diseases?
![Page 42: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/42.jpg)
West Nile Virus
Description Also West Nile Encephalitis Affects humans, mammals, birds First noted in Uganda, has spread to several parts of
the world In 2007 = 3630 cases, 124 fatalities
Etiology Birds are reservoirs for the virus -> bitten by
mosquito -> mosquito picks up live virus -> transmitted to humans and other animals via mosquito bite
![Page 43: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/43.jpg)
West Nile Virus
Signs and Symptoms Only seen in 20% of infected people, usually mild Fever, headache, swollen lymph nodes, skin rash, eye
pain Can be neurological involvement, developing
encephalitis or meningitis
Treatment Prevention of mosquito bites Gloves when handling dead animals and birds No vaccination available
![Page 44: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/44.jpg)
Physical Therapy Interventions
For West Nile Virus
Physical therapy may be indicated during more advanced stages of the disease as problems arise with mental and physical abilities. The patient’s physical functioning may be impacted.
![Page 45: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/45.jpg)
WORKING IN HEALTH CARE, THE PTA WILL BE EXPOSED TO MANY OF THESE DISEASES. IMMUNITY TO THESE
DISEASES WILL PROTECT THE PTA.
Why does the PTA need to know about infectious disease immunity?
![Page 46: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/46.jpg)
Preventable Infectious Diseases for Which Health Care Workers are Required to Have Immunity
Diphtheria Corynebacterium diphtheriae bacteria
Mumps Paramyxovirus
Pertussis (whooping cough) Bacteria Bordetella pertussis or Bordetella
parapertussis
![Page 47: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/47.jpg)
Preventable Infectious Diseases for Which Health Care Workers are Required to Have Immunity
Poliomyelitis and post-polio syndrome Virus
Rubella (German measles) Virus
Rubeola (measles) Single-strand RNA Morbillivirus
![Page 48: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/48.jpg)
Preventable Infectious Diseases for Which Health Care Workers are Required to Have Immunity
Tetanus Bacteria Clostridium tetani
Varicella (chicken pox – children, shingles - adults) Herpes zoster virus
![Page 49: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/49.jpg)
OTHER INFECTIONS ARE COMMONLY SEEN IN HEALTH CARE, AND THE PTA WILL NEED
TO UNDERSTAND THE PRECAUTIONS RELATED TO THE DISEASES. IN ADDITION,
THE PTA NEEDS TO BE AWARE OF THE DISEASES THAT MAY BE INVOLVED IN A
TERRORIST ATTACK.
Why does the PTA need to know about other infectious diseases?
![Page 50: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/50.jpg)
Botulism
Description Food poisoning In U.S, 145 people / year diagnosed; infants
Etiology Clostridium botulinum in bottled or canned foods Bacterial spores produce toxins which prevent
acetylcholine release -> paralysis
![Page 51: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/51.jpg)
Botulism
Signs and Symptoms Usually symptoms w/in 36 hours, but can be up to 10
days Abdominal cramping, double vision, dry mouth,
nausea, respiratory problems, vomiting dysphagia, dysphasia, weakness, paralysis
Neurological symptoms up to 1 year
Treatment Botulinus antitoxin; antimicrobial medications
ineffective Mechanical ventilation, IV fluids, feeding tube
![Page 52: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/52.jpg)
Physical Therapy Interventions
For Botulism
Physical therapy may be indicated for respiratory therapy during the acute phase, and for neurological rehabilitation, weakness, and paralysis if necessary during recovery.
![Page 53: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/53.jpg)
Influenza
Description Affects upper respiratory tract Influenza viruses A and B Between 5% - 20% of the U.S. population annually;
with approx. 36,000 deaths Older adults, young children, people with other
diseases are at greatest risk Types change frequently -> immunizations do not
affect all strains Viral pneumonia from influenza can cause secondary
bacterial infection
![Page 54: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/54.jpg)
Influenza
Etiology Spread through droplets by coughing, sneezing; through
direct contact with eyes and mouth
Signs and Symptoms From mild to severe Cough, high fever, sore throat, dyspnea, muscle aches,
headache, diarrhea, vomiting
Treatment Prevention through vaccine Rest, fluids, avoid alcohol and smoking
![Page 55: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/55.jpg)
Physical Therapy Interventions
For Influenza
It is important for all health care workers to be vaccinated against influenza, to avoid posing a risk of infection for susceptible populations.
Chest PT may be indicated if pneumonia has developed.
![Page 56: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/56.jpg)
Meningitis
Description Inflammation of meninges in brain and spinal cord Most common in people under age 30 Indemic in parts of Africa and India
Etiology Viruses (enteroviruses), bacteria (cryptococcal,
Escherichia coli, meningococcal, pneumococcal, staphylococcal, streptococcal, syphilitic and tuberculous
![Page 57: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/57.jpg)
Meningitis
Signs and Symptoms Viral meningitis milder, up to 2 weeks Bacterial meningits sudden, more severe Fever, nausea, vomiting light sensitivity, headaches,
meningismus, altered levels of consciousness, seizures, tachypnea, agitation, opisthotonus, decreased appetite
Treatment Prevention through vaccination Antibacterial medications; no medications for viral type Hospitalization, IV fluids, antiseizure medications
![Page 58: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/58.jpg)
Physical Therapy Interventions
For Meningitis
PTAs may treat patients with meningitis who have suffered neurological deficits, with treatment focused on functional rehabilitation, activities of daily living, and prevention of deformities.
![Page 59: INFECTIOUS DISEASES PTA 120 Pathophysiology Day 16](https://reader031.vdocuments.us/reader031/viewer/2022022215/56649e235503460f94b10756/html5/thumbnails/59.jpg)
Questions